Ebba Biotech AB
Ebba Biotech AB is a Swedish biotech company that develops and sells fluorescent optotracer molecules (Amytracker, EbbaBiolight, Carbotrace) for detecting amyloid protein aggregates, bacterial biofilms, and plant carbohydrates, serving academic researchers, CROs, and industry in 40+ countries.
- Company typePrivate
- Founded2016
- HeadquartersSolna, Sweden
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ebba Biotech AB does
Ebba Biotech AB is a privately held Swedish biotechnology company founded in 2016 and headquartered at the Karolinska Institutet Science Park in Solna, Sweden. The company develops and commercializes luminescent conjugated oligothiophene (LCO) fluorescent tracer molecules, branded as "optotracers," which fluoresce only when bound to specific biological targets. Its portfolio spans three core product lines: Amytracker (amyloid and protein aggregate detection in tissue, cells, and in vivo models), EbbaBiolight (bacterial extracellular matrix and biofilm visualization), and Carbotrace (non-destructive carbohydrate and glucan analysis for plant biomass research). Each line is offered in five spectral variants (480-680 nm) and multiple formulations including aqueous, DMSO, solid (for IV injection), and ready-to-use Drop&Shine mounting media. A complementary Carbotrace Testing Service provides laboratory-based carbohydrate analysis for customers seeking guidance on product selection.
The company sells directly through its e-commerce storefront and via a global distributor network reaching 40+ countries, with a documented customer mix of 37% academia, 31% industry, and 32% distributors. Pricing is transparent and modest, ranging from EUR 200 for individual Amytracker variants to EUR 500 for Mix&Try bundles and EUR 2,000 for premium listings. Marketing relies heavily on scientific credibility, supported by 120+ peer-reviewed publications and 30+ papers in 2025 alone, rather than paid advertising. Ebba Biotech maintains deep institutional ties with Karolinska Institutet through co-founder Ferdinand X. Choong (Assistant Professor and AIMES Team Leader) and Founder/Chairman Prof. Agneta Richter-Dahlfors, and has cultivated commercial partnerships with Inscopix (miniscope integration), reMYND/InnoSer (CRO protocol adoption), and Cytacoat AB (anti-fouling catheter coatings). With 1-10 employees and no disclosed external funding, Ebba Biotech operates as a lean, research-tools supplier whose growth depends on publication-driven adoption and distributor-led geographic expansion.
Ebba Biotech AB firmographics
Firmographics- Name
- Ebba Biotech AB
- Legal name
- Ebba Biotech AB
- Website
- https://ebbabiotech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ebba Biotech AB is a Swedish biotech company that develops and sells fluorescent optotracer molecules (Amytracker, EbbaBiolight, Carbotrace) for detecting amyloid protein aggregates, bacterial biofilms, and plant carbohydrates, serving academic researchers, CROs, and industry in 40+ countries.
- Ownership category
- akta.pro rank
Ebba Biotech AB industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Proteomics & Biomarker Analytical Testing (HLAGADAG), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Ebba Biotech AB is headquartered
LocationHeadquarters
- HQ city
- Solna
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Ebba Biotech AB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Revenue model
- Product sales - Amytracker, EbbaBiolight, Carbotrace: Sale of fluorescent optotracer reagents in multiple formulations (aqueous, DMSO, solid, Drop&Shine) and spectral variants (480, 520, 540, 630, 680 nm peak emission). Products sold directly via e-commerce and through global distributors. Mix&Try bundled products available at 500 EUR.
- Carbotrace Testing Service: Laboratory testing service for carbohydrate analysis using Carbotrace optotracer technology, providing spectrophotometric analysis and data interpretation for customers who need assistance determining the best Carbotrace molecule for their analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Amytracker Mix&Try bundle |
| Unit Pricing | Pay-as-you-go | Amytracker 680 - single variant |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Ebba Biotech AB product offering
Product offeringCore offering
Ebba Biotech AB develops and commercializes fluorescent optotracer reagents based on luminescent conjugated oligothiophenes (LCOs) for visualizing biological nanostructures in research applications. The portfolio comprises three product lines: Amytracker (protein aggregate/amyloid detection), EbbaBiolight (bacterial and biofilm imaging), and Carbotrace (carbohydrate analysis), sold in multiple spectral variants and formulations. A laboratory-based Carbotrace Testing Service is also offered to assist customers with sample analysis and product selection.
Product overview
Ebba Biotech AB develops and commercializes fluorescent optotracer molecules for visualizing nanostructures in biological research. The product portfolio consists of three core product lines: Amytracker for amyloid and protein aggregate detection, EbbaBiolight for bacterial biofilm visualization, and Carbotrace for carbohydrate/glucan analysis. The products are small fluorescent dye molecules that bind to specific biological targets and are used with fluorescence microscopy, plate readers, and other imaging equipment. A Carbotrace Testing Service is also offered to help researchers select the appropriate product variant for their needs.
Differentiator
Problem solved
Functional benefit
Brands
- Amytracker: Fluorescent tracer molecules for detection of protein aggregates suitable for fibrillation assays, fixed or fresh tissue sections, cells, and in vivo systemic injection. Available in five variants (480, 520, 540, 630, 680) specified by peak emission wavelength.
- EbbaBiolight
- Carbotrace
Products and services
- Amytracker
Quantifiable outcome
- Amytracker is 10x brighter than Congo Red and detects amyloid in 15% of Congo Red negative samples
- +1 more outcomes
Companies that use Ebba Biotech AB
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
Ebba Biotech AB technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Ebba Biotech AB partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Karolinska Institutet (AIMES - Center for the Advancement of Integrated Medical and Engineering Sciences)coreEbba Biotech was co-founded by researchers from Karolinska Institutet. Co-founder Ferdinand X. Choong is Team Leader at AIMES, and founder Prof. Agneta Richter-Dahlfors is Professor at Karolinska Institutet. AIMES is a joint center funded by KTH Royal Institute of Technology and Karolinska Institutet, promoting interdisciplinary research. Multiple publications and testimonials cite research conducted at AIMES using Ebba Biotech products, indicating ongoing collaborative R&D relationship.
- reMYND (InnoSer)minorreMYND is a Contract Research Organization that has integrated Amytracker 520 into its preclinical research protocols for Alzheimer's and Parkinson's disease mouse models. Their Science Director, Tom Cornelissen, provided a testimonial highlighting the exceptional results with Amytracker 520 for detecting pathological features in brain tissue.
- InscopixminorInscopix, a company developing miniaturized microscopes (nVista miniscope) for in vivo brain imaging, has incorporated Amytracker 520 into their platform. Senior Research Scientist Shan Huang provided a testimonial noting Amytracker 520's exceptional performance for labeling A-beta plaques in vivo in 5xFAD mice with high signal-to-noise and efficient blood-brain barrier crossing.
- Cytacoat ABminorCytacoat AB, in collaboration with Karolinska Institutet and University of Southampton, used EbbaBiolight as part of research developing LubriShield, a novel anti-fouling coating for urinary catheters to prevent biofilm-related infections.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Ebba Biotech AB competitors and assessment
Company assessmentDirect peers
- Biotium: Biotium (now part of Abcam) develops fluorescent dyes and probes for life science research, including protein aggregate and cell biology stains. It is a direct comparable in size, focus, and distribution model (e-commerce + distributors), making it the closest peer to Ebba Biotech's optotracer reagent business.
- Lumiprobe: Lumiprobe manufactures specialty fluorescent dyes for biology and diagnostics, including reactive dyes and protein labels sold through e-commerce globally. Comparable as a similarly-sized fluorescent-probe specialist with a similar online + distributor go-to-market.
- ATTO-Tec: ATTO-Tec develops high-performance fluorescent dyes used in microscopy, flow cytometry, and bioanalytics. Comparable as a specialty dye manufacturer targeting similar imaging and life-science research customers as Ebba Biotech.
- StressMarq Biosciences: StressMarq supplies amyloid reagents, recombinant proteins, and antibodies for neurodegeneration research. Directly comparable product overlap with Ebba's Amytracker line for Alzheimer's, Parkinson's, and prion research.
- AnaSpec (Eurofins): AnaSpec (now part of Eurofins) provides custom peptides, fluorescent probes, and amyloid research reagents. Direct overlap with Ebba Biotech's amyloid and protein-aggregate detection product line and similar customer base.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher's Life Science Solutions division sells an extensive catalog of fluorescent reagents, amyloid stains, and protein-aggregate detection kits under the Invitrogen and Thermo Scientific brands. A broad incumbent with overlapping capabilities rather than a niche competitor.
- Bio-Techne: Bio-Techne (including R&D Systems and Tocris) offers proteins, antibodies, and small-molecule probes for neuroscience and cell biology. Overlaps with Ebba Biotech through reagents targeting protein aggregation and neurodegenerative disease research.
- Merck (Sigma-Aldrich): Merck's life science division (Sigma-Aldrich, Millipore) distributes a broad catalog of fluorescent dyes, including thioflavin variants and Congo Red used as benchmark amyloid stains. Comparable as the dominant incumbent against whose legacy dyes Ebba Biotech competes.
- Abcam (Danaher): Abcam, now part of Danaher, supplies antibodies and reagents for protein research, including antibodies targeting amyloid aggregates. Comparable as a broad incumbent serving the same academic and industry neuroscience customers as Ebba Biotech.
- Li-Cor Biosciences: Li-Cor develops infrared fluorescent dyes and imaging systems for Western blots, microscopy, and in vivo imaging. Comparable as a specialty fluorescent-probe and imaging company with overlapping applications in protein-aggregate detection workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ebba Biotech AB social profiles
Digital presenceEbba Biotech AB financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ebba Biotech AB leadership team
Management profileNumber of profiles
Profiles3 records
Ebba Biotech AB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ebba Biotech AB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ebba Biotech AB
What does Ebba Biotech AB do?
Ebba Biotech AB develops and commercializes fluorescent optotracer reagents based on luminescent conjugated oligothiophenes (LCOs) for visualizing biological nanostructures in research applications. The portfolio comprises three product lines: Amytracker (protein aggregate/amyloid detection), EbbaBiolight (bacterial and biofilm imaging), and Carbotrace (carbohydrate analysis), sold in multiple spectral variants and formulations. A laboratory-based Carbotrace Testing Service is also offered to assist customers with sample analysis and product selection.
Is Ebba Biotech AB a public or private company?
Ebba Biotech AB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ebba Biotech AB founded?
Ebba Biotech AB was founded in 2016. It employs 1 to 10 people.
Where is Ebba Biotech AB based?
Ebba Biotech AB is headquartered in Solna, Sweden, in the Europe region.
How does Ebba Biotech AB make money?
Two revenue lines are on record. Product sales - Amytracker, EbbaBiolight, Carbotrace is the primary driver. The others are carbotrace Testing Service.
Who are Ebba Biotech AB's main competitors?
Direct peers on record are Biotium, Lumiprobe, ATTO-Tec, StressMarq Biosciences and AnaSpec (Eurofins). Broad incumbents are Thermo Fisher Scientific, Bio-Techne, Merck (Sigma-Aldrich), Abcam (Danaher) and Li-Cor Biosciences.
Does Ebba Biotech AB have an API?
No public API is recorded for Ebba Biotech AB.
What industry is Ebba Biotech AB in?
Ebba Biotech AB's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 541714 and its SIC code is 8731.